1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Textiles: new trials by email Literature Review of Textiles trials Research Report on Textiles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis WO3970, Qbrexza® (glycopyrronium) cloth, 2.4%, for topical use - Primary Axillary Hyperhidrosis | Phase 2 | Withdrawn | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2019-12-01 | 2024-12-24 | |
| Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects XF-73 nasal gel, Placebo nasal gel, Chlorhexidine gluconate 2% topical cloths - Staphylococcus Aureus Infection | Phase 1 / Phase 2 | Completed | Destiny Pharma Plc | 60 | 2014-09-01 | 2016-10-07 |
Hyperhidrosis (1) · Staphylococcal Infections (1)
Destiny Pharma Plc (1) · Dr. August Wolff GmbH & Co. KG Arzneimittel (1)
United Kingdom (1)